Healthcare & Life Sciences
Intercept Tx
France
series-c-plus
series-c-plus
Stage
1
Investors
About
Intercept Tx develops treatments targeting infectious diseases with a focus on innovative therapeutic solutions to improve patient outcomes.
Explore Intercept Tx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.